When Lee Giller’s breast cancer returned in November 2012, he faced a prognosis of 26 months to live.
So the 58-year-old Akron businessman, whose estrogen-receptor-positive and BRCA 1 breast cancer had spread to his bones, liver and lungs, said it “didn’t take much arm-twisting” to convince him to join a clinical trial to test a new treatment.
Read more: post-gazette.com
